Interesting that the cannacord valuation was raised from $1.35 to $1.90 (31st Jan 16) so they must have lowered it and then raised it.
Agree with most of what you said.
Just wonder why nothing has been said about the European market? Anyone?
Patent protection but wonder why they use 12 year DCF model w no value. Is that because of patents or is that a standard thing?
Wonder how much next cap raise will be.
Interesting that the cannacord valuation was raised from $1.35...
Add AXP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.64M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $0 | 54 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 60 | 119857338 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 148982177 | 63 |
View Market Depth
| Last trade - 10.00am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.1¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.1¢ | 0.1¢ | 0.1¢ | 1000000 | ||
| Last updated 10.12am 04/06/2024 ? | |||||
| AXP (ASX) Chart |